🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Juvenile Idiopathic Arthritis (JIA)

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis NCT03773965Phase 378 sites📍 Rosario📍 SAN M. de Tucuman📍 Melbourne Eli Lilly and Company · Tests: Baricitinib Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA NCT05310799NA1 site📍 Vancouver University of British Columbia · Tests: Shared Decision Making (SDM) Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis NCT05754710n/a1 site📍 Seoul Pfizer · Tests: Xeljanz OLE Study With Filgotinib in JIA NCT07553182Phase 34 sites📍 Le Kremlin-Bicêtre📍 Hamburg📍 Sankt Augustin Alfasigma S.p.A. · Tests: Filgotinib A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease NCT07203001Phase 223 sites📍 Cincinnati📍 Portland📍 Salt Lake City Novartis Pharmaceuticals · Tests: MAS825 Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis NCT07517575Phase 214 sites📍 Kazan'📍 Moscow📍 Moscow R-Pharm International, LLC · Tests: OKZ q4w, OKZ q4w Pain in Juvenile Arthritis NCT07217782NA1 site📍 St Louis Washington University School of Medicine · Tests: Pressure pain thresholds (measured in kilopascal), Cold pain tolerance (duration in seconds) An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis NCT06668181Phase 323 sites📍 Calgary📍 Montreal📍 Saskatoon UCB Biopharma SRL · Tests: Bimekizumab Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases NCT07184450Phase 11 site📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: BCMA/CD70-targetd CAR-T Ilaris NIS in Korea NCT06838143n/a1 site📍 Seoul Novartis Pharmaceuticals · Tests: Ilaris Virtual Self-Management Program for JIA NCT06184100NA1 site📍 Calgary University of Calgary · Tests: Virtual Self-Management Program (SMP), No Intervention STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS NCT03728478Phase 31 site📍 Genova Istituto Giannina Gaslini · Tests: Etanercept, Methotrexate, Intra-articular corticosteroid injections UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease NCT06560606n/a19 sites📍 Calgary📍 Edmonton📍 Vancouver The Hospital for Sick Children M3-JIA: Making Mindfulness Matter for Children With JIA NCT06376149NA3 sites📍 Hamilton📍 London📍 Toronto London Health Sciences Centre Research Institute OR Lawson … · Tests: M3 Intervention group, M3 Waitlist Group Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions NCT04833465n/a1 site📍 Washington D.C. Children's National Research Institute · Tests: No Intervention Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis. NCT07845942n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis NCT07234747NA1 site📍 Istanbul Istanbul University - Cerrahpasa · Tests: Structured Core Stabilization Exercise Training, Exergaming-Based Core Stabilization Training Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients NCT07185750n/a1 site📍 Çankaya Hacettepe University · Tests: Questionnaire application for JIA cases and their parents To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. NCT05925452NA10 sites📍 Beijing📍 Chongqing📍 Changsha Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: GenaKumab Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study. NCT06862843n/a4 sites📍 Florence📍 Roma📍 Foggia Meyer Children's Hospital IRCCS · Tests: Collecting questionnaires and biological samples Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA NCT06870045n/a1 site📍 Istanbul Istanbul University - Cerrahpasa · Tests: Physical examination, Dynamic Gait Index Angiogenic Biomarkers in Juvenile Idiopathic Arthritis NCT05534347n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sample, Joint puncture Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis NCT06874608NA1 site📍 Florence Meyer Children's Hospital IRCCS · Tests: complete, polymeric formula, fiber, lactose and gluten free Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis NCT06806774n/a2 sites📍 Ankara📍 Ankara Hacettepe University Feasibility of a Diet Intervention for Juvenile Arthritis NCT06474546NA7 sites📍 Winnipeg📍 Hamilton📍 London The Hospital for Sick Children · Tests: Diet intervention Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain NCT07602595n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Not applicable- observational study Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty NCT07138898Phase 21 site📍 New York NYU Langone Health · Tests: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide, Azathioprine Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults NCT07000916n/a1 site📍 Brussels Université Catholique de Louvain Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea NCT07243782n/a1 site📍 Seoul Novartis Pharmaceuticals · Tests: Secukinumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy